Focused Alpha LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$713K Buy
775
+102
+15% +$103K 0.22% 97
2025
Q4
$723K Buy
+673
New +$644K 0.21% 94

Other funds holding LLY

Focused Alpha LLC's LLY Position: Q1 2026 in Review

Focused Alpha LLC increased its Eli Lilly (LLY) stake by 15% in Q1 2026, buying an estimated $103K and bringing the position to 775 shares worth $713K. The position accounts for 0.22% of the portfolio, ranked #97.

Focused Alpha LLC first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $723K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Focused Alpha LLC held 775 shares of Eli Lilly worth $713K as of Q1 2026.
  • Focused Alpha LLC bought 102 Eli Lilly shares in Q1 2026, an estimated $103K.
  • Eli Lilly made up 0.22% of Focused Alpha LLC's portfolio in Q1 2026, its #97 holding.
  • Focused Alpha LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Focused Alpha LLC's Eli Lilly position peaked at $723K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Focused Alpha LLC's 13F filing for Q1 2026, filed 12 May 2026.